256 related articles for article (PubMed ID: 27465598)
21. Response to the Comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors.
Siebert R; Schuh A; Ott G; Cree IA; Du MQ; Ferry J; Hochhaus A; Naresh KN; Solary E; Khoury JD
Leukemia; 2023 May; 37(5):1170-1172. PubMed ID: 36973349
[No Abstract] [Full Text] [Related]
22. Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gaillard JB; Chapiro E; Daudignon A; Nadal N; Penther D; Chauzeix J; Nguyen-Khac F; Veronese L; Lefebvre C
Curr Res Transl Med; 2023; 71(4):103428. PubMed ID: 38016421
[TBL] [Abstract][Full Text] [Related]
23. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH).
Rack KA; van den Berg E; Haferlach C; Beverloo HB; Costa D; Espinet B; Foot N; Jeffries S; Martin K; O'Connor S; Schoumans J; Talley P; Telford N; Stioui S; Zemanova Z; Hastings RJ
Leukemia; 2020 Aug; 34(8):2262-2264. PubMed ID: 32042082
[No Abstract] [Full Text] [Related]
24. Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Nguyen-Khac F; Balogh Z; Chauzeix J; Veronese L; Chapiro E
Curr Res Transl Med; 2023; 71(4):103410. PubMed ID: 38039634
[TBL] [Abstract][Full Text] [Related]
25. Cytogenetics in the management of clonal chromosomal abnormalities of undetermined significance and persistent polyclonal B-cell lymphocytosis: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Nadal N; Auger N; Bidet A; Nguyen-Khac F
Curr Res Transl Med; 2023; 71(4):103426. PubMed ID: 38016423
[TBL] [Abstract][Full Text] [Related]
26. Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH).
Dastugue N; Lafage-Pochitaloff M; Pagès MP; Radford I; Bastard C; Talmant P; Mozziconacci MJ; Léonard C; Bilhou-Nabéra C; Cabrol C; Capodano AM; Cornillet-Lefebvre P; Lessard M; Mugneret F; Pérot C; Taviaux S; Fenneteaux O; Duchayne E; Berger R;
Blood; 2002 Jul; 100(2):618-26. PubMed ID: 12091356
[TBL] [Abstract][Full Text] [Related]
27. Molecular landscape of mature B-cell lymphoproliferative disorders with BCL3-translocation: A Groupe Francophone de Cytogénétique Hématologique (GFCH)/French Innovative Leukemia Organization (FILO) study.
Véronèse L; Bensaber H; Dannus LT; Giannone G; Choiset C; Grimpret C; Abermil N; Balducci E; Bidet A; Chapiro E; Couronné L; Daudignon A; Douet-Gilbert N; Eclache V; Gaillard B; Gaillard JB; Hsoumi F; Lefebvre C; Nadal N; Mozziconacci MJ; Penther D; Ribourtout B; Richebourg S; Rigollet L; Terre C; Soler G; Tournilhac O; Guièze R; Nguyen-Khac F; Tchirkov A
Am J Hematol; 2024 May; ():. PubMed ID: 38817040
[No Abstract] [Full Text] [Related]
28. t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH).
Berger R; Dastugue N; Busson M; Van Den Akker J; Pérot C; Ballerini P; Hagemeijer A; Michaux L; Charrin C; Pages MP; Mugneret F; Andrieux J; Talmant P; Hélias C; Mauvieux L; Lafage-Pochitaloff M; Mozziconacci MJ; Cornillet-Lefebvre P; Radford I; Asnafi V; Bilhou-Nabera C; Nguyen Khac F; Léonard C; Speleman F; Poppe B; Bastard C; Taviaux S; Quilichini B; Herens C; Grégoire MJ; Cavé H; Bernard OA;
Leukemia; 2003 Sep; 17(9):1851-7. PubMed ID: 12970786
[TBL] [Abstract][Full Text] [Related]
29. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
[TBL] [Abstract][Full Text] [Related]
30. Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology.
Hussaini M
Cancer Control; 2015 Apr; 22(2):158-66. PubMed ID: 26068760
[TBL] [Abstract][Full Text] [Related]
31. Metaphase harvest and cytogenetic analysis of malignant hematological specimens.
Dal Cin P; McLaughlin C
Curr Protoc Hum Genet; 2012 Apr; Chapter 10():Unit 10.2.1-15. PubMed ID: 22470141
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic study of 75 erythroleukemias.
Lessard M; Struski S; Leymarie V; Flandrin G; Lafage-Pochitaloff M; Mozziconacci MJ; Talmant P; Bastard C; Charrin C; Baranger L; Hélias C; Cornillet-Lefebvre P; Mugneret F; Cabrol C; Pagès MP; Fert-Ferret D; Nguyen-Khac F; Quilichini B; Barin C; Berger R;
Cancer Genet Cytogenet; 2005 Dec; 163(2):113-22. PubMed ID: 16337853
[TBL] [Abstract][Full Text] [Related]
33. Implication of cytogenetic and molecular cytogenetic analysis in diagnosis of hematological malignancies in the era of the new sequencing techniques.
Zemanová Z; Michalová K; Březinová J
Cas Lek Cesk; 2019; 158(1):22-27. PubMed ID: 31046388
[TBL] [Abstract][Full Text] [Related]
34. [Necessity of Genetic Examination in Treatment for Hematological Malignancies].
Kiyoi H
Rinsho Byori; 2015 Mar; 63(3):369-76. PubMed ID: 26524860
[TBL] [Abstract][Full Text] [Related]
35. Molecular Diagnosis of Hematopoietic Neoplasms: 2018 Update.
Ramchandren R; Jazaerly T; Bluth MH; Gabali AM
Clin Lab Med; 2018 Jun; 38(2):293-310. PubMed ID: 29776632
[TBL] [Abstract][Full Text] [Related]
36. [Genetic analysis and immunophenotyping in the diagnosis of hematological disease].
Hergersberg M; Röthlisberger B; Heijnen IA; Huber AR
Ther Umsch; 2004 Feb; 61(2):83-91. PubMed ID: 15018391
[TBL] [Abstract][Full Text] [Related]
37. Whole genome scanning as a cytogenetic tool in hematologic malignancies.
Maciejewski JP; Mufti GJ
Blood; 2008 Aug; 112(4):965-74. PubMed ID: 18505780
[TBL] [Abstract][Full Text] [Related]
38. t(10;11)(p13-14;q14-21): a new recurrent translocation in T-cell acute lymphoblastic leukemias. Groupe Français de Cytogénétique Hématologique (GFCH).
Genes Chromosomes Cancer; 1991 Nov; 3(6):411-5. PubMed ID: 1777411
[TBL] [Abstract][Full Text] [Related]
39. Abnormalities of the long arm of chromosome 21 in 107 patients with hematopoietic disorders: a collaborative retrospective study of the Groupe Français de Cytogénétique Hématologique.
Jeandidier E; Dastugue N; Mugneret F; Lafage-Pochitaloff M; Mozziconacci MJ; Herens C; Michaux L; Verellen-Dumoulin C; Talmant P; Cornillet-Lefebvre P; Luquet I; Charrin C; Barin C; Collonge-Rame MA; Pérot C; Van den Akker J; Grégoire MJ; Jonveaux P; Baranger L; Eclache-Saudreau V; Pagès MP; Cabrol C; Terré C; Berger R;
Cancer Genet Cytogenet; 2006 Apr; 166(1):1-11. PubMed ID: 16616106
[TBL] [Abstract][Full Text] [Related]
40. [Recommendations for performing cytogenetic studies in hematological malignancies].
Solé F; Espinet B; Woessner S
Sangre (Barc); 1999 Feb; 44(1):73-5. PubMed ID: 10323101
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
